Objective: To determine the relationship between maternal ABO blood group and risk of adverse pregnancy outcomes.
Introduction
The ABO blood group is the first and the most well-known blood type system in humans. 1 This blood system has important roles in human physiology, biomedical science, anthropology, legal issues, as well as transfusion and transplantation medicine. 1, 2 The blood group of an individual is controlled by a single gene (the ABO gene) located on the long arm of chromosome 9 (9q34) with three variant alleles: A, B and O. 3 The A and B alleles encode some specific enzymes (glycosyltransferases) that produce both A (glycosyltransferase a1,3-GalNAc-transferase) and B (a1,3Gal-transferase) antigens. 3, 4 The O allele encodes an inactive glycosyltransferase, hence neither A nor B antigen is synthesized. 3 Both A and B antigens are found on the surface of red blood cells and other tissues including vascular endothelium, epidermis and glandular or other epitheliums lining visceras. 5 Aside from its physiologic role, recent studies have shown associations between particular ABO phenotypes and various pathologic events, for example, infection, bleeding disorder, thromboembolic disease, cancers and so on. [6] [7] [8] [9] The possible mechanisms for the associations are the influences of some genetic variants at the ABO locus on the aberrations of some biological substances, such as proinflammatory cytokine, adhesion molecules and thrombogenic factor. 10, 11 The effects of blood types on pregnancy outcomes have also been reported, however, with inconsistent results. [12] [13] [14] [15] Some authors found a greater risk of preeclampsia in women with A or AB blood types, 12-14 whereas another study found that percentage of O blood type was high among women with gestational diabetes mellitus (GDM). 16 Others did not find any relationship between maternal blood group and pregnancy outcomes including preeclampsia, postpartum hemorrhage, intrauterine growth restriction, large for gestational age (GA) infants or stillbirth. 15 Bearing in mind the limited data from a few studies with inconsistent results, additional information is needed. Furthermore, all previous studies were carried out in Western populations with possibly different distributions of ABO phenotypes from Asian women. Hence, more research on this subject is necessary. The aim of this study was to evaluate the relationship between maternal ABO blood group and risks of pregnancy complications or adverse pregnancy outcomes in Thai women. More specifically, we focused on the complications or adverse outcomes that were previously reported on this topic and the ones that are presently recognized as unfavorable pregnancy outcomes. These included preeclampsia, GDM, preterm delivery, low birth weight (LBW) and small for GA (SGA) infants.
Methods

This study was approved by the Bangkok Metropolitan Administration Ethics Committee for Research Involving Human
Subjects. We performed a retrospective analysis of all consecutive Thai pregnant women who attended our antenatal clinic between 1 July 2008 and 30 June 2010. Inclusion criteria were singleton pregnancies who sought their first antenatal care at GA p14 weeks, and who underwent ABO blood typing along with other basic antenatal care laboratory investigations in our institution. Exclusion criteria were those who had: known underlying disease or condition that could affect the pregnancy outcomes (that is, chronic hypertension, overt diabetes, renal or collagen vascular disease, hyperthyroidism, smoking or congenital fetal anomalies), Rhnegative blood type, delivery elsewhere and incomplete clinical data. Data collected were: maternal age, parity, body mass index at first visit, ABO blood group, GA at delivery, route of delivery, neonatal birth weight and adverse pregnancy outcomes. ABO blood group was determined by a standard blood group serology analysis. This included both testing of A and B antigens on red blood cells (with anti-A and anti-B reagents) and testing of anti-A and anti-B antibodies in serum (with A and B antigens). The result of each test was certified by laboratory personnel before submitting the final report. Pregnancy complications or adverse pregnancy outcomes in this study included preeclampsia, GDM, preterm delivery, LBW and SGA infants. Preeclampsia was defined based on the guideline of the American College of Obstetricians and Gynecologists. 17 All women were screened for GDM. Those with a positive screen were scheduled for a diagnostic test. The diagnosis of GDM was based on the Carpenter and Coustan criteria. 18 Preterm delivery included a delivery before the completion of 37 weeks of gestation. Neonatal birth weights <2500 g or under the 10th percentile for that particular GA, using a Thai infant birth weight nomogram, 19 were considered LBW or SGA infants, respectively.
Statistical analysis was performed with the SPSS software package version 11.5 (SPSS, Chicago, IL, USA). Continuous variables among the four groups of women with different blood types (A, B, AB or O) were compared by using one-way analysis of variance; when overall analysis was significant, the intergroup comparisons were then made by the Scheffe method. Categorical variables between groups were compared with the w 2 test. Owing to its absence of both A and B antigens, O blood type was used as the reference group. The relative risks (RRs) with 95% confidence intervals (CIs) of the five outcomes studied in A, B and AB blood types were analyzed by stepwise logistic regression adjusted for potential confounders. P-value <0.05 was considered statistically significant.
Results
A total of 5320 gravidas were included in this study; 50.2% were nulliparous. Mean age and body mass index at first visit were 27.0 ± 6.3 years and 22.2 ± 4.3 kg m À2 , respectively. The distribution of ABO phenotypes in the study population was as follows: A ¼ 21.7%, B ¼ 34.4%, AB ¼ 7.1% and O ¼ 36.8%. Among women with four different blood types, no significant differences in terms of teenage or elderly mothers, rate of nullipara and percentages of overweight or obesity were observed. Details of the characteristic features of the study population are presented in Table 1 .
Out of 5320 women, 350 (6.6%), 333 (6.3%) and 543 (10.2%) had preeclampsia, GDM and preterm delivery, respectively. With regard to their babies, 394 (7.4%) and 178 (3.3%) were, respectively, diagnosed with LBW and SGA infants. Table 2 presents birth outcomes of the women. There were no significant differences of GA at delivery, route of delivery or neonatal birth weight among the four groups of women with different blood types. Table 3 compares the adverse pregnancy outcomes or pregnancy complications among women with A, B, AB, and O phenotypes. By univariable analysis, women with A or AB blood types, but not B, had significantly higher risk of preeclampsia than O type individuals. We used multivariable analysis to adjust for potential confounders for preeclampsia, including age, parity, body mass index as well as the other variables in the Table. Both A and AB phenotypes were identified as independent risk factors for preeclampsia (RR, 1.7; 95% CI, 1.3 to 2.3; P ¼ 0.001 and RR, 1.7; 95% CI, 1.1 to 2.6; P ¼ 0.01, respectively). On the other hand, uniand multivariable analyses did not show significant relationships between blood types and GDM, preterm delivery, LBW or SGA.
Upon further analysis, we found that the degree of RRs increased as the clinical manifestations of hypertensive disorders became more severe. The adjusted RRs of gestational hypertension, mild preeclampsia and severe preeclampsia in A blood type were 1.0 (95% CI, 0.6 to 1.8; P>0.05), 1.6 (95% CI, 1.1 to 2.3; P ¼ 0.01) and 2.1 (95% CI, 1.3 to 3.3; P<0.01), respectively, whereas the respective adjusted RRs in AB blood type were 1.1 (95% CI, 0.4 to 2.6; P>0.05), 1.6 (95% CI, 1.1 to 2.8; P ¼ 0.04) and 1.8 (95% CI, 1.1 to 3.6; P ¼ 0.03).
Discussion
The ABO blood group is the most important blood type system in humans especially in medicine. The distribution of ABO phenotypes Comparison is between cesarean and vaginal routes. Table 3 Adverse pregnancy outcomes of the four groups of women according to their blood phenotypes Abbreviations: CI, confidence interval; GDM, gestational diabetes mellitus; LBW, low birth weight; RR, relative risk; SGA, small for gestational age. a Adjusted for age, parity, body mass index and other adverse pregnancy outcomes in the Table. ABO blood group and pregnancy outcomes C Phaloprakarn and S Tangjitgamol varies across the globe, depending on racial/ethnic origins and geographic regions. For example, A blood type is more common than the other blood types in Japan and European countries, whereas O type predominates in the United States. 20 O blood type is also the most common blood type found in Thai population followed by B, A and AB types: 37.8% for O type, 34.8% for B, 20.5% for A and 6.9% for AB. 21 Our study that focused only on pregnant women also found similar distribution of blood types as those encountered in the general Thai population. 21 Several studies have shown associations between particular ABO phenotypes and pregnancy complications. In a study conducted by May, British women with A blood type had a 2.7-fold risk of preeclampsia compared with O type individuals. 13 Similarly, Spinillo et al.
14 and Hiltunen et al. 12 found an increased risk of preeclampsia by 2.1-to 3.1-folds in Italian and Finnish gravidas with AB blood type compared with O type women. However, the impact of blood types on pregnancy complications was not observed by Clark et al. who conducted a study on Scottish women. 15 In our study, we also found that both A and AB blood types were significantly associated with preeclampsia; however, the 1.7-fold risk in either blood group was smaller than those observed in previous reports.
12 -14 Different results regarding the magnitude of associations among these studies might lie on various sample sizes, racial/ethnic origins studied, and population characteristics (that is, primigravidas in the studies of May and Spinillo et al. vs a combination of primi-and multigravidas in the studies of Hiltunen et al., Clark et al. and our study).
We also found a direct association of degree of RRs with severity of preeclampsia in A and AB blood types. Our results were consistent with the findings of Hiltunen et al.
12 who reported RRs of 2.1 for preeclampsia as a whole and 2.3 specifically for severe preeclampsia in AB type individuals. Knowing the risk of specific type of hypertensive disorders (that is, mild or severe preeclampsia) may be clinically useful because the maternal and neonatal prognosis as well as pregnancy management depend on the severity of the disease.
There are several hypotheses for the observed relationship between ABO blood types and preeclampsia. One possible mechanism is due to an effect of von Willebrand factor, which was found higher in non-O (A, B, and AB) compared with O type individuals. 22 Evidence suggests that von Willebrand factor can promote platelet aggregation/adhesion and atherosis formation leading to endothelial dysfunction, which is known to be involved in the pathogenesis of preeclampsia. [23] [24] [25] Other mechanisms may also get involved because our study found only an increased risk of preeclampsia in women with A and AB blood types, but not B type gravidas. Some inflammatory markers, that is, tumor necrosis factor-alpha and soluble intercellular adhesion molecule 1 were identified to be upregulated by single-nucleotide polymorphism rs651007 at the ABO locus, especially with the A allele. 10, 11, 26 As these markers are associated with preeclampsia, [27] [28] [29] this is therefore another possible mechanism.
It is well recognized that SGA shares the same underlying pathogenesis with preeclampsia. However, our study could not demonstrate association of a particular ABO phenotype with the risk of having an SGA infant as we found with preeclampsia. This might be due to the small number of subjects studied. Nevertheless, we found that A blood type was a significant risk factor for coincidental events of SGA and preeclampsia (rather than SGA alone) with an adjusted RR of 3.4 (95% CI, 1.1 to 9.9; P ¼ 0.03). Further studies with larger sample sizes might verify the potential influence of ABO phenotype on this pregnancy outcome.
One previous study identified a higher prevalence of O blood type in gravidas with GDM compared with non-GDM group (52.2% vs 33.3%). 16 However, evaluation of the risk factors for GDM was not the main purpose of such a study, so information on the RR of this pregnancy complication in relation to maternal blood group was not reported. In our study, we found that the RRs of GDM among the four blood phenotypes were comparable. Similarly, we observed no associations of blood types with preterm delivery or LBW. These negative results may serve as basic data for future research to look for other genetic variants that may link to such complications. This is the first study to evaluate the impact of ABO blood types on maternal and neonatal outcomes in Asian population. The strength of our study was that it was conducted on a large cohort of pregnant women. Additionally, all of the study population underwent blood group testing, therefore information on blood phenotypes was considered accurate. At the same time, some drawbacks of this study were recognized. First of all, as this was a retrospective study, data on other potential risk factors for the outcomes being investigated were not available, such as, history of preeclampsia or GDM in prior pregnancies and so on. However, we adjusted for known potential confounders by using multivariable analysis. Second, the possible impact of minor red blood cell antibodies on adverse pregnancy outcomes could not be addressed because the majority of the study population was not crossmatched. Third, we did not include Rh-negative blood group subjects because of its low incidence (<0.5%) in Thai population. 30 Consequently, impact on women with this particular blood type was not determined. Lastly, the possible influences of neonatal or paternal ABO blood types on pregnancy outcomes could not be assessed because additional blood testing was not possible in our retrospective study. These limitations may be minimized in future and prospective studies.
In conclusion, our results demonstrated that maternal ABO blood group was associated with the risk of preeclampsia, but not with GDM, preterm delivery, LBW or SGA. A and AB blood types were independent risk factors for preeclampsia and the degree of RRs varied directly with the severity of the disease. Our findings might have a role in identifying women at risk and to alert a clinician to the possibility of a case of preeclampsia and proactive early detection. At all times, we were aware of the limitations regarding the small proportion of A and AB phenotypes in our population and of the modest increased risk of preeclampsia in either blood type. Hence, one could not draw a final conclusion from our results until further research with various population groups further validate our findings.
